Emergency department use by patients who received chimeric antigen receptor T cell infusion therapy.

Lipe DN, Qdaisat A, Chaftari P, Wattana MK, Krishnamani PP, Reyes-Gibby C, Yeung SJ.

Open source

DOI
10.3389/fonc.2023.1122329
Published
2023-03-17
Container
Front Oncol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2023.1122329,
  title = {Emergency department use by patients who received chimeric antigen receptor T cell infusion therapy.},
  author = {Lipe DN and  Qdaisat A and  Chaftari P and  Wattana MK and  Krishnamani PP and  Reyes-Gibby C and  Yeung SJ.},
  year = {2023},
  journal = {Front Oncol},
  doi = {10.3389/fonc.2023.1122329},
  url = {https://doi.org/10.3389/fonc.2023.1122329}
}

RIS

TY  - JOUR
TI  - Emergency department use by patients who received chimeric antigen receptor T cell infusion therapy.
AU  - Lipe DN
AU  -  Qdaisat A
AU  -  Chaftari P
AU  -  Wattana MK
AU  -  Krishnamani PP
AU  -  Reyes-Gibby C
AU  -  Yeung SJ.
PY  - 2023
JO  - Front Oncol
DO  - 10.3389/fonc.2023.1122329
UR  - https://doi.org/10.3389/fonc.2023.1122329
ER  - 

APA

DN, L., A, Q., P, C., MK, W., PP, K., C, R., & SJ., Y. (2023). Emergency department use by patients who received chimeric antigen receptor T cell infusion therapy.. Front Oncol. https://doi.org/10.3389/fonc.2023.1122329

Source records